PRTG

Portage Biotech (PRTG)

About Portage Biotech (PRTG)

Portage Biotech, Inc. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. Its portfolio includes first-in-class invariant natural killer T cell (iNKT) small molecule engagers and best-in-class adenosine antagonists. The company was founded by Gregory H. Bailey and James Mellon in 1973 and is headquartered in Road Town, British Virgin Islands.

Details

Daily high
$4.77
Daily low
$4.39
Price at open
$4.62
52 Week High
$23.01
52 Week Low
$2.10
Market cap
3.1M
Dividend yield
0.00%
Volume
7,787
Avg. volume
133,409
P/E ratio
-.07

Portage Biotech News

Details

Daily high
$4.77
Daily low
$4.39
Price at open
$4.62
52 Week High
$23.01
52 Week Low
$2.10
Market cap
3.1M
Dividend yield
0.00%
Volume
7,787
Avg. volume
133,409
P/E ratio
-.07